They play a dual role in the TME: antitumor effector CD8+ T cells recognize and kill tumor cells, whereas immunosuppressive regulatory T cells (Tregs) inhibit immune cell functions and promote tumor immune escape [43]. The gene discussed is CD8A; the disease is neoplasm.